Citadel Advisors’s Omega Protein OME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-44,918
Closed -$748K 8785
2017
Q3
$748K Buy
44,918
+26,161
+139% +$425K ﹤0.01% 4743
2017
Q2
$336K Buy
+18,757
New +$350K ﹤0.01% 5722
2016
Q4
Sell
-58,624
Closed -$1.37M 8246
2016
Q3
$1.37M Buy
58,624
+32,395
+124% +$761K ﹤0.01% 3448
2016
Q2
$524K Buy
+26,229
New +$490K ﹤0.01% 4420
2015
Q2
Sell
-98,761
Closed -$1.35M 9327
2015
Q1
$1.35M Buy
98,761
+74,666
+310% +$862K ﹤0.01% 3568
2014
Q4
$255K Sell
24,095
-40,778
-63% -$483K ﹤0.01% 5665
2014
Q3
$811K Buy
64,873
+41,512
+178% +$579K ﹤0.01% 3979
2014
Q2
$320K Sell
23,361
-26,074
-53% -$341K ﹤0.01% 4996
2014
Q1
$597K Buy
49,435
+36,598
+285% +$419K ﹤0.01% 4094
2013
Q4
$158K Buy
+12,837
New +$151K ﹤0.01% 5249

Citadel Advisors's OME Position: Q4 2017 in Review

Citadel Advisors sold out of Omega Protein (OME) in Q4 2017, closing a stake of 44,918 shares — an estimated $748K sold.

Citadel Advisors first reported a position in OME in Q4 2013 and held it in 10 quarters. The position peaked at $1.37M in Q3 2016. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.

  • Citadel Advisors reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
  • Citadel Advisors sold 44,918 Omega Protein shares in Q4 2017, an estimated $748K.
  • Citadel Advisors first reported a position in Omega Protein in Q4 2013 and held it in 10 quarters.
  • Citadel Advisors's Omega Protein position peaked at $1.37M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.

Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.